These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 33773007)

  • 41. Early Antibody-Mediated Kidney Transplant Rejection Associated With Anti-Vimentin Antibodies: A Case Report.
    Rampersad C; Shaw J; Gibson IW; Wiebe C; Rush DN; Nickerson PW; Ho J
    Am J Kidney Dis; 2020 Jan; 75(1):138-143. PubMed ID: 31515140
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of disease severity and outcome of hospitalized renal transplant recipients with COVID-19 infection: a systematic review of a globally representative sample.
    Hasan I; Rashid T; Suliman S; Amer H; Chirila RM; Mai ML; Jarmi T; Khouzam S; Franco PM; Heilig CW; Wadei HM
    Rom J Intern Med; 2021 Mar; 59(1):10-42. PubMed ID: 33155999
    [No Abstract]   [Full Text] [Related]  

  • 44. Collapsing Focal Segmental Glomerulosclerosis and Acute Oxalate Nephropathy in a Patient With COVID-19: A Double Whammy.
    Malhotra V; Magoon S; Troyer DA; McCune TR
    J Investig Med High Impact Case Rep; 2020; 8():2324709620963635. PubMed ID: 33019829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of antibody mediated rejection shortly after acute cellular rejection in a pediatric kidney transplantation recipient.
    Okada M; Kamei K; Matsuoka K; Ito S
    CEN Case Rep; 2018 Nov; 7(2):288-291. PubMed ID: 29949115
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia.
    Alberici F; Delbarba E; Manenti C; Econimo L; Valerio F; Pola A; Maffei C; Possenti S; Zambetti N; Moscato M; Venturini M; Affatato S; Gaggiotti M; Bossini N; Scolari F
    Kidney Int; 2020 Jun; 97(6):1083-1088. PubMed ID: 32354634
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Histopathologic findings on indication renal allograft biopsies after recovery from acute COVID-19.
    Basic-Jukic N; Coric M; Bulimbasic S; Dika Z; Juric I; Furic-Cunko V; Katalinic L; Kos J; Fistrek M; Kastelan Z; Jelakovic B
    Clin Transplant; 2021 Dec; 35(12):e14486. PubMed ID: 34532893
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Focal and segmental glomerulosclerosis in renal allograft recipients: a clinico-pathologic study of 37 cases.
    Gupta R; Sharma A; Mahanta PJ; Agarwal SK; Dinda AK
    Saudi J Kidney Dis Transpl; 2013 Jan; 24(1):8-14. PubMed ID: 23354185
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Belatacept for kidney transplant recipients.
    Masson P; Henderson L; Chapman JR; Craig JC; Webster AC
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010699. PubMed ID: 25416857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunosuppression in kidney transplant recipients with COVID-19 infection - where do we stand and where are we heading?
    Daoud A; Alqassieh A; Alkhader D; Posadas Salas MA; Rao V; Fülöp T; Soliman KM
    Ren Fail; 2021 Dec; 43(1):273-280. PubMed ID: 33491531
    [TBL] [Abstract][Full Text] [Related]  

  • 51. COVID-19 Associated Collapsing FSGS in an APOL1 Homozygous Transplant Recipient After Successful COVID Vaccination: A Case Report.
    Chen S; Kowalewska J; McCune TR
    Transplant Proc; 2022; 54(6):1543-1546. PubMed ID: 34924204
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyponatremia: A possible immuno-neuroendocrine interface with COVID-19 in a kidney transplant recipient.
    Tantisattamo E; Reddy UG; Duong DK; Ferrey AJ; Ichii H; Dafoe DC; Kalantar-Zadeh K
    Transpl Infect Dis; 2020 Dec; 22(6):e13355. PubMed ID: 32510756
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recurrence of proteinuria 10 years post-transplant in NPHS2-associated focal segmental glomerulosclerosis after conversion from cyclosporin A to sirolimus.
    Höcker B; Knüppel T; Waldherr R; Schaefer F; Weber S; Tönshoff B
    Pediatr Nephrol; 2006 Oct; 21(10):1476-9. PubMed ID: 16721582
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft.
    Von Visger J; Cassol C; Nori U; Franco-Ahumada G; Nadasdy T; Satoskar AA
    BMC Nephrol; 2019 Feb; 20(1):53. PubMed ID: 30764798
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coronavirus disease 2019 (COVID-19) in the heart transplant population: a single-centre experience.
    Caraffa R; Bagozzi L; Fiocco A; Bifulco O; Nadali M; Ponzoni M; Carrozzini M; Toscano G; Fraiese AP; Metra M; Lombardi CM; Serafini F; Ribola A; Jorgji V; Bottio T; Gerosa G
    Eur J Cardiothorac Surg; 2020 Nov; 58(5):899-906. PubMed ID: 33084868
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kidney allograft biopsy findings after COVID-19.
    Daniel E; Sekulic M; Kudose S; Kubin C; Ye X; Shayan K; Patel A; Cohen DJ; E Ratner L; Santoriello D; Barry Stokes M; Markowitz GS; Pereira MR; D'Agati VD; Batal I
    Am J Transplant; 2021 Dec; 21(12):4032-4042. PubMed ID: 34403563
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spectrum of podocytopathies in new-onset nephrotic syndrome following COVID-19 disease: a report of 2 cases.
    Gupta RK; Bhargava R; Shaukat AA; Albert E; Leggat J
    BMC Nephrol; 2020 Aug; 21(1):326. PubMed ID: 32753052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. COVID-19-related collapsing glomerulopathy revealing a rare risk variant of APOL1: lessons for the clinical nephrologist.
    Laboux T; Gibier JB; Pottier N; Glowacki F; Hamroun A
    J Nephrol; 2021 Apr; 34(2):373-378. PubMed ID: 33548053
    [No Abstract]   [Full Text] [Related]  

  • 59. Primary focal segmental glomerulosclerosis recurring rapidly as collapsing glomerulopathy in a renal allograft recipient.
    Agrawal V; Prasad N; Singh P
    Saudi J Kidney Dis Transpl; 2017; 28(3):621-624. PubMed ID: 28540902
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bortezomib in the treatment of antibody-mediated rejection in pediatric kidney transplant recipients: A multicenter Midwest Pediatric Nephrology Consortium study.
    Kizilbash S; Claes D; Ashoor I; Chen A; Jandeska S; Matar RB; Misurac J; Sherbotie J; Twombley K; Verghese P
    Pediatr Transplant; 2017 May; 21(3):. PubMed ID: 28092129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.